"We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions."

During the past decade, Sanofi-Aventis Administrative Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis Administrative Office" #1 collaborator was "Bristol-Myers Squibb" with 5 trials as a collaborator, "Cancer International Research Group (CIRG)" with 2 trials as a collaborator, "Groupe Oncologie Radiotherapie Tete et Cou" with 1 trials as a collaborator, "Population Health Research Institute" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis Administrative Office" are "Atrial Fibrillation" (6 trials), "Venous Thromboembolism" (5 trials), "Alzheimer Disease" (2 trials), "Atrial Flutter" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Sanofi-Aventis Administrative Office" in a lesser frequency.

Most popular intervention types in "Sanofi-Aventis Administrative Office" are "Drug" (48 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (9 trials), "Placebo" (8 trials), "Semuloparin sodium" (4 trials), "Docetaxel" (3 trials) and "Enoxaparin sodium" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sanofi-Aventis Administrative Office" are 44 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Sanofi-Aventis Administrative Office". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Sanofi-Aventis Administrative Office, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Sanofi-Aventis Administrative Office, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".